| Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention (NCT06318559) | Fondazione del Piemonte per l'Oncologia | 2022-06-29 |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| Retzius-sparing Technique in Robotic-assisted Radical Prostatectomy (NCT05224024) | Ankara University | 2022-02-15 |
| Onco-primary Care Networking to Support TEAM-based Care (NCT04258813) | Duke University | 2021-06-14 |
| Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA (NCT04319783) | Trans Tasman Radiation Oncology Group | 2021-06-02 |
| A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer (NCT04633252) | National Cancer Institute (NCI) | 2021-02-23 |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors (NCT04541225) | Nuvation Bio Inc. | 2020-12-08 |
| Tailored, wEb-based, Psychosocial and Physical Activity Self-Management PrOgramme (NCT04304196) | St. Mary's Research Center, Canada | 2020-06-01 |
| Hypertension Management in Cancer Patients (NCT03919214) | Duke University | 2019-12-10 |
| Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP (NCT03899077) | Cancer Research Antwerp | 2019-04-05 |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (NCT03896958) | SpeciCare | 2019-03-21 |
| De-implementation of Low Value Castration for Men With Prostate Cancer (NCT03579680) | University of Michigan | 2018-08-22 |
| Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia (NCT03444532) | Danish Cancer Society | 2018-03-02 |
| Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer (NCT03354416) | National Cancer Institute (NCI) | 2018-02-26 |
| Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy (NCT03388619) | National Cancer Institute (NCI) | 2018-01-17 |
| A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer (NCT03450109) | Luye Pharma Group Ltd. | 2017-12-22 |
| 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer (NCT03181867) | National Cancer Institute (NCI) | 2017-08-03 |
| Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy (NCT03442075) | Instituto Mexicano del Seguro Social | 2017-05-01 |
| Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) (NCT03133286) | DxTerity Diagnostics | 2017-04-06 |
| Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI) (NCT03031418) | Exosome Diagnostics, Inc. | 2016-09-01 |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors (NCT02957357) | Alliance Foundation Trials, LLC. | 2016-02-01 |
| Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients (NCT02614859) | Fox Chase Cancer Center | 2015-12-01 |
| Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 (NCT02362464) | National Cancer Institute (NCI) | 2015-05-12 |
| Prostatic Cancer Versus Androgen Deficiency (NCT02235142) | Hopital Foch | 2013-06-03 |
| Sipuleucel-T Manufacturing Demonstration Study (NCT01477749) | Dendreon | 2012-06-01 |
| Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci (NCT01639859) | Hospices Civils de Lyon | 2011-10-01 |
| Dynamic Focusing Evaluation for Prostate Cancer Treatment (NCT03632980) | EDAP TMS S.A. | 2011-06-01 |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) (NCT02564120) | UNC Lineberger Comprehensive Cancer Center | 2011-01-01 |
| Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator (NCT00999960) | Assistance Publique - Hôpitaux de Paris | 2010-02-01 |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer (NCT00970203) | Roswell Park Cancer Institute | 2009-09-01 |
| Collection of Blood From Patients With Prostate Cancer (NCT00923221) | National Cancer Institute (NCI) | 2007-02-28 |
| A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer (NCT00220194) | San Bernardino Urological Associates Medical Group Inc | 2003-04-01 |
| A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy (NCT00257478) | Astellas Pharma Inc | |